Spyre Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Spyre Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2015 to Q3 2024.
  • Spyre Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 51.4M shares, a 1169% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 51.4M +47.3M +1169% Sep 30, 2024 10-Q/A 2024-11-18
Q2 2024 50.8M -30.2M -37.3% Jun 30, 2024 10-Q/A 2024-11-18
Q1 2024 36.6M -28.8M -44% Mar 31, 2024 10-Q/A 2024-11-18
Q4 2023 36.1M +33.4M +1279% Dec 31, 2023 10-Q/A 2024-11-18
Q3 2023 4.05M -57.5M -93.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 81M +19.8M +32.4% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 65.4M +16M +32.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 2.61M -46.7M -94.7% Dec 31, 2022 10-K/A 2024-11-18
Q3 2022 61.5M +12.2M +24.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 61.2M +12.1M +24.8% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 49.4M +400K +0.82% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 49.4M +1.4M +2.91% Dec 31, 2021 10-K 2023-03-02
Q3 2021 49.3M +4.61M +10.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 49M +4.43M +9.92% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 49M +19.9M +68.2% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 48M +18.9M +64.9% Dec 31, 2020 10-K 2022-03-08
Q3 2020 44.7M +15.8M +54.5% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 44.6M +15.8M +54.6% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 29.1M +310K +1.08% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 29.1M +4.94M +20.5% Dec 31, 2019 10-K 2021-03-18
Q3 2019 28.9M +6.83M +30.9% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 28.8M +6.94M +31.7% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 28.8M +12M +71.6% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 24.1M +7.47M +44.8% Dec 31, 2018 10-K 2020-02-24
Q3 2018 22.1M +5.63M +34.1% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 21.9M +5.46M +33.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 16.8M +3.36M +25% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 16.7M +3.24M +24.1% Dec 31, 2017 10-K 2019-03-07
Q3 2017 16.5M +3.04M +22.6% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 16.5M +3.04M +22.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 13.5M +12.7M +1676% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 13.4M +12.7M +1673% Dec 31, 2016 10-K 2018-03-13
Q3 2016 13.4M Sep 30, 2016 10-Q 2016-11-09
Q2 2016 13.4M Jun 30, 2016 10-Q 2016-08-09
Q1 2016 757K Mar 31, 2016 10-Q 2016-05-19
Q4 2015 757K Dec 31, 2015 10-K 2017-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.